/Lists

Biotech Investors & VC Firms in New York

186 firms in this list, with a median first check of $500K. 50 of them lead rounds. Generated from verified public data and updated continuously.

Lever VC
New YorkPre-Seed–Series A$100K – $5M
17 people
Redesign Health
New YorkSeed
27 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
18 people
Essex Woodlands Healthcare Partners
New YorkGrowth$20M – $80M
18 people
Adjuvant Capital
New YorkSeries A–Series B$10M – $25M
20 people
Social Impact Capital
New YorkPre-Seed–Series A$100K – $1.5M
20 people
Able Partners
New YorkPre-Seed–Series A$500K – $3M
3 people
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
Altaris Capital Partners
New York
22 people
Plum Alley Investments
New YorkSeed–Series A$500K – $1.5M
15 people
Gore Range Capital
New YorkSeries A–Late Stage$500K – $5M
17 people
BIOSPRING PARTNERS
New YorkGrowth
23 people
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Oberland Capital
New YorkGrowth–Late Stage
20 people
Oncology Ventures
New YorkSeed–Series A
17 people
Deviation Capital
New YorkSeed–Growth
16 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
Carbon Direct
New York
21 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
8 people
LDV Capital
New YorkPre-Seed–Seed$500K – $1.5M
7 people
Divergent Capital
New YorkPre-Seed–Seed$250K – $1M
7 people
Commodore Capital
New YorkSeries C–Late Stage
20 people
Alger
New York
19 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.